Literature DB >> 35276041

Exposing the Brain Proteomic Signatures of Alzheimer's Disease in Diverse Racial Groups: Leveraging Multiple Data Sets and Machine Learning.

Heather Desaire1, Kaitlyn E Stepler2, Renã A S Robinson2,3,4,5,6.   

Abstract

Recent studies have highlighted that the proteome can be used to identify potential biomarker candidates for Alzheimer's disease (AD) in diverse cohorts. Furthermore, the racial and ethnic background of participants is an important factor to consider to ensure the effectiveness of potential biomarkers for representative populations. A promising approach to survey potential biomarker candidates for diagnosing AD in diverse cohorts is the application of machine learning to proteomics data sets. Herein, we leveraged six existing bottom-up proteomics data sets, which included non-Hispanic White, African American/Black, and Hispanic participants, to study protein changes in AD and cognitively unimpaired participants. Machine learning models were applied to these data sets and resulted in the identification of amyloid-β precursor protein (APP) and heat shock protein β-1 (HSPB1) as two proteins that have high ability to distinguish AD; however, each protein's performance varied based upon the racial and ethnic background of the participants. HSPB1 particularly was helpful for generating high areas under the curve (AUCs) for African American/Black participants. Overall, HSPB1 improved the performance of the machine learning models when combined with APP and/or participant age and is a potential candidate that should be further explored in AD biomarker discovery efforts.

Entities:  

Keywords:  APP; AUCs; African American; Alzheimer’s disease; amyloid-β precursor protein; heat shock protein; machine learning; proteomics

Mesh:

Substances:

Year:  2022        PMID: 35276041      PMCID: PMC9097891          DOI: 10.1021/acs.jproteome.1c00966

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   5.370


  59 in total

1.  An interdisciplinary outreach model of African American recruitment for Alzheimer's disease research.

Authors:  Monique M Williams; Marie M Meisel; James Williams; John C Morris
Journal:  Gerontologist       Date:  2010-12-20

Review 2.  Machine learning applications in proteomics research: how the past can boost the future.

Authors:  Pieter Kelchtermans; Wout Bittremieux; Kurt De Grave; Sven Degroeve; Jan Ramon; Kris Laukens; Dirk Valkenborg; Harald Barsnes; Lennart Martens
Journal:  Proteomics       Date:  2014-01-21       Impact factor: 3.984

3.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

4.  Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles.

Authors:  Zoltán Nemes; B Devreese; P M Steinert; J Van Beeumen; L Fésüs
Journal:  FASEB J       Date:  2004-05-07       Impact factor: 5.191

Review 5.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Biomarkers for Alzheimer Dementia in Diverse Racial and Ethnic Minorities-A Public Health Priority.

Authors:  Lisa L Barnes
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

7.  Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.

Authors:  Mostafa J Khan; Heather Desaire; Oscar L Lopez; M Ilyas Kamboh; Renã A S Robinson
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

8.  Brain site-specific proteome changes in aging-related dementia.

Authors:  Arulmani Manavalan; Manisha Mishra; Lin Feng; Siu Kwan Sze; Hiroyasu Akatsu; Klaus Heese
Journal:  Exp Mol Med       Date:  2013-09-06       Impact factor: 8.718

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

Review 10.  Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review.

Authors:  Andrea L Gilmore-Bykovskyi; Yuanyuan Jin; Carey Gleason; Susan Flowers-Benton; Laura M Block; Peggye Dilworth-Anderson; Lisa L Barnes; Manish N Shah; Megan Zuelsdorff
Journal:  Alzheimers Dement (N Y)       Date:  2019-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.